Latest Marfan syndrome Stories
Wimbledon Health Partners, the leading on-site diagnostic testing organization which provides vascular, echocardiogram and NCV testing, is proud to recognize the role athletic trainers have in
Walt "Clyde" Frazier, Former NY Knicks Standout, is a Special Guest PORT WASHINGTON, N.Y., March 9, 2015 /PRNewswire/ -- The Marfan Foundation announced today that it is honoring Isaiah
Wimbledon Health Partners supports Marfan Syndrome Awareness Month and its national efforts to promote research, increase awareness and support those dealing with the disease. Boca
Wimbledon Health Partners' collegiate testing division Wimbledon U delivers on-site diagnostic testing to colleges and universities.
Inaugural 2014 Harrington Prize for Innovation in Medicine CLEVELAND, Feb.
A team of investigators has developed an innovative blood test that may provide a faster, simpler way for emergency room doctors and others to diagnose and monitor potentially deadly aortic aneurysms and aortic dissections (a tear in the wall of the aorta) for which early diagnosis is critical for survival.
Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected.
Systemic complications include life-threatening thoracic aortic disease
Marfan's syndrome is a genetic disorder of the connective tissue that causes excessively tall stature and long extremities. It is carried by the gene FBN1, which encodes the connective protein fibrillin-1, and is a dominant trait. The human genetic makeup contains a pair of FBN1 genes, so because of its dominance, inheriting one affected FBN1 gene from either parent will result in Marfan's syndrome. It effects both males and females, and has no ethnic bias. It was named after Antoine Marfan,...